TTK Healthcare to sell EVA and Good Home brands for ₹256 crore

TTK Healthcare has approved the sale of its EVA and Good Home brands to Wipro Enterprises Private Limited for a total consideration of ₹256 crore plus applicable GST. The transaction, subject to customary conditions precedent, is expected to close by September 30, 2026. This divestment involves brands that contributed approximately 17% to the company's total turnover in FY 2025-26.

Deal Overview

The Board of Directors approved the proposal based on the recommendation of the Audit Committee. Definitive agreements were signed on July 23, 2026. The buyer, Wipro Enterprises Private Limited, does not belong to the promoter group of TTK Healthcare, and the transaction is not classified as a related party transaction or a slump sale.

Parameter	Details
Seller	TTK Healthcare
Buyer	Wipro Enterprises Private Limited
Brands Being Sold	EVA and Good Home
Transaction Value	₹256 crore plus applicable GST
Expected Closing Date	September 30, 2026

Financial Impact

The EVA and Good Home brands generated a revenue of approximately ₹148 crore in FY 2025-26. This amount represented 17% of the total turnover of the company for the financial year. The sale proceeds will be realised upon the successful closing of the transaction.

1 Day	5 Days	1 Month	6 Months	1 Year	5 Years
+0.65%	+1.73%	+8.93%	+3.25%	-25.16%	+26.03%

TTK Healthcare has drawn attention from prominent investor Sunil Singhania, with his investment firm Abakkus reporting a 2.07% stake in the company as per Q1 shareholding disclosures. The disclosure highlights notable institutional interest in the healthcare firm.

Stake Details

The following table summarises the key details of the reported stake:

Parameter:	Details
Investor:	Sunil Singhania (Abakkus)
Stake Reported:	2.07%
Reporting Period:	Q1

The stake, attributed to Abakkus—the investment platform founded by Sunil Singhania—was captured in the Q1 shareholding pattern of TTK Healthcare. Such disclosures are made when an investor's holding meets or exceeds the threshold requiring public reporting under applicable regulations.

Significance of the Disclosure

Sunil Singhania is a well-recognised name in Indian equity markets, and disclosures of his firm's positions in listed companies are closely tracked by market participants. The reported 2.07% holding in TTK Healthcare reflects Abakkus's presence as a shareholder of note in the company during the stated quarter. No further details regarding the nature of the transaction, acquisition price, or any changes from prior quarters were included in the available data.